Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Retatrutide is an investigational once-weekly subcutaneous triple agonist targeting GLP-1, GIP, and glucagon receptors, developed by Eli Lilly
Choose LifeVantage MindBody GLP-1 if: You want a non-prescription, non-injectable approach to appetite management You have mild weight management goals (losing 10-20 pounds) You understand it will not produce pharmaceutical-level results You value gut health and fiber supplementation alongside weight management You cannot access or tolerate injectable GLP-1 medications You accept the price premium of the MLM distribution model Consider alternatives if: You need significant weight loss (30+ pounds) for health reasons You have type 2 diabetes requiring evidence-based treatment Budget is a concern (standalone ingredients cost 50-65% less) You want strong clinical evidence behind your investment You are comparing it to affordable compounded GLP-1 medications at similar price points The bottom line LifeVantage has created a product that combines several ingredients with plausible mechanisms for modestly supporting natural GLP-1 production
A less obvious B12 deficiency can also develop, marked by elevated homocysteine levels
That means its amazing for calming irritated skin, rosacea, or even eczema
[PMC free article][PubMed] [CrossRef] Winter SC
If you need help interpreting test results, reassessing your supplement intake or you would like a second opinion considering booking a consultation.
